• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Home
  • About
  • Podcast
  • Archives

Atomic Insights

Atomic energy technology, politics, and perceptions from a nuclear energy insider who served as a US nuclear submarine engineer officer

Radioimmunontherapy (RIT) for follicular lymphoma

December 21, 2012 By Rod Adams

Andrew Schorr, the founder and host of Patient Power, interviewed Dr. Anton Hagenbeek of the University Medical Center Utrecht Netherlands about the result of clinical trials of radioimmunotherapy (RIT) to combat follicular lymphoma. The treatment uses a monoclonal antibody that is covalently bound to Y-90, which is a beta emitter. The monoclonal antibody selectively binds itself to the cancer cells to allow the Y-90 betas to target and destroy the invasive tissue.

Dr. Hagenbeek agreed when Schorr described this approach as a smart bomb approach that produces less damage to innocent bystanders. Though I have no intention of attempting to summarize the lengthy discussion, I will say that I was impressed when Dr. Hagenbeek favorably compared the effectiveness of a single dose of RIT to 16 injections of rituximab (one every 2-3 months over a three year period.) He was surprisingly reserved in his description of the incredible lifestyle improvement that the single dose of radioimmunotherapy provides compared to the 16 doses of chemotherapy.

Robert Schenter shared the above video interview which was conducted at the American Society of Hematology Meeting in 2011. This video has been available on YouTube for about 18 months, but it has only been viewed about 215 times. It is hard to believe that such interesting news about a cost and time effective cancer treatment has received such little attention.

Filed Under: Advanced Atomic Technologies, Health Effects, isotopes

About Rod Adams

Rod Adams is an atomic energy expert with small nuclear plant operating and design experience, now serving as a Managing Partner at Nucleation Capital, an emerging climate-focused fund. Rod, a former submarine Engineer Officer and founder of Adams Atomic Engines, Inc., one of the earliest advanced nuclear ventures, has engaged in technical, strategic, political, historic and financial discussion and analysis of the nuclear industry, its technology and policies for several decades. He is the founder of Atomic Insights and host and producer of The Atomic Show Podcast.

Please click here to subscribe to the Atomic Show RSS feed.

Reader Interactions

Comments

  1. SJ Razi says

    December 21, 2012 at 5:38 PM

    Because it is radiation. God forbid anything good comes out of radiation even though life evolved during the Archean and Proterozoic with much higher levels of background radiation.

Primary Sidebar

Categories

Join Rod’s pronuclear network

Join Rod's pronuclear network by completing this form. Let us know what your specific interests are.

Recent Comments

  • David on Atomic Show #297 – Krusty – The Kilopower reactor that worked
  • Rod Adams on Atomic Show #297 – Krusty – The Kilopower reactor that worked
  • David on Atomic Show #297 – Krusty – The Kilopower reactor that worked
  • Rod Adams on Atomic Show #297 – Krusty – The Kilopower reactor that worked
  • paul wick on Atomic Show #297 – Krusty – The Kilopower reactor that worked

Follow Atomic Insights

The Atomic Show

Atomic Insights

Recent Posts

Atomic Show #297 – Krusty – The Kilopower reactor that worked

Nuclear energy growth prospects and secure uranium supplies

Nucleation Capital’s Earth Day in Atherton

Atomic Show #296 – Julia Pyke, Director of Finance Sizewell C

Solar’s dirty secrets: How solar power hurts people and the planet

  • Home
  • About Atomic Insights
  • Atomic Show
  • Contact
  • Links

Search Atomic Insights

Archives

Copyright © 2022 · Atomic Insights

Terms and Conditions - Privacy Policy